Icosavax, Inc. is a Seattle, Washington-based clinical-stage biopharmaceutical company specializing in developing novel vaccines utilizing virus-like particle technology.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Icosavax, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Icosavax, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.